SEC 13F Intelligence

Bml Capital Management, LLC / 2KZ0

Bml Capital Management, LLC’s Kezar Life Sciences Inc Position

Does Bml Capital Management, LLC own Kezar Life Sciences Inc (2KZ0)? Yes — 720.8K shares worth $5M (+3.43% of its 13F portfolio) as of Q1 2026.

Position Value
$5M
Q1 2026
Shares
720.8K
% of Portfolio
+3.43%
Quarters Held
6
currently held

Position History 2KZ0

Reported value by quarter
Q4 ’24: $327,049Q4 ’24Q1 ’25: $2MQ1 ’25Q2 ’25: $3MQ2 ’25Q3 ’25: $3MQ3 ’25Q4 ’25: $5MQ4 ’25Q1 ’26: $5MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026720.8K$5M+3.43%
Q4 2025720.8K$5M+3.92%
Q3 2025720.8K$3M+2.57%
Q2 2025635.2K$3M+2.20%
Q1 2025408.1K$2M+1.61%
Q4 202448.7K$327,049+0.20%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bml Capital Management, LLC’s full portfolio or all institutional holders of 2KZ0.